<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03820661</url>
  </required_header>
  <id_info>
    <org_study_id>18-5982</org_study_id>
    <nct_id>NCT03820661</nct_id>
  </id_info>
  <brief_title>High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma</brief_title>
  <official_title>Advancing The Local Staging Of Pancreatic Ductal Adenocarcinoma Through High-Resolution Ultrasound: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will
      undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is
      being done to see if using high resolution ultrasound before and during surgery will help the
      doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has
      spread to other areas of the body.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC</measure>
    <time_frame>within 2 weeks of surgery</time_frame>
    <description>The U/S results will be compared to pre-operative CT scan to help determine the diagnostic effectiveness of High Resolution US</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pancreatic Ductal Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>High Resolution Ultasound</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diagnostic high resolution ultrasound pre-operatively and intraoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>High resolution ultrasound pre-operatively and intra-operatively</description>
    <arm_group_label>High Resolution Ultasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females &gt; 18 y

          2. PDAC diagnosed by typical imaging findings or pathology

          3. Scheduled for surgical resection

          4. Contrast enhanced CT scan performed locally at UHN

        Exclusion Criteria:

        1) Inability or unwillingness to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korosh Khalili, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie Ramotar</last_name>
    <phone>416-946-4501</phone>
    <phone_ext>2657</phone_ext>
    <email>Stephanie.Ramotar@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dorian Anglin Facey</last_name>
    <phone>416 340 4800</phone>
    <phone_ext>5095</phone_ext>
    <email>dorian.facey@uhn.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorian Facey</last_name>
      <phone>4377797757</phone>
    </contact>
    <contact_backup>
      <last_name>Stephanie Ramotar</last_name>
    </contact_backup>
    <investigator>
      <last_name>Korosh Khalili</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>January 11, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>May 6, 2019</last_update_submitted>
  <last_update_submitted_qc>May 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

